RADHIKA PATEL: Open Payments
NPI 1285154278 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 64 payments from 17 companies in 2025. Trend: 2023 $949 · 2024 $1,327 · 2025 $1,547
Food & beverage: $1,547
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $464 |
| AstraZeneca Pharmaceuticals LP | 15 | $256 |
| Merck Sharp & Dohme LLC | 12 | $210 |
| Ardelyx, Inc. | 6 | $116 |
| Medtronic, Inc. | 1 | $103 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Exact Sciences Corporation | 2 | $48 |
| Lilly USA, LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
Products named: JARDIANCE, VERQUVO, IBSRELA, FARXIGA, COBALT DR MRI SURESCAN, LEQVIO, CAPVAXIVE, SHINGRIX.
Industry payments across NJ — which companies pay providers there.
